Health

Persistent Systems, Persistent

Persistent launches population health management solution using Microsoft Azure OpenAI Service

Persistent Systems, a global Digital Engineering and Enterprise Modernization leader, on Thursday launched a Generative AI-powered Population Health Management (PHM) Solution in collaboration with Microsoft.

|
Glenmark

Glenmark launches biosimilar of anti‐diabetic drug Liraglutide

Pharmaceutical company Glenmark has launched a biosimilar of the popular anti‐diabetic drug, Liraglutide, for the first time in India.

|
MedTech

MTaI unveils India’s historic $464 mn MedTech FDI leap

India has witnessed a record-breaking surge of $464 million in foreign investments in MedTech in the first 3 quarters, the Medical Technology Association of India (MTaI), which represents

|
Laryngectomy,

Overcoming Laryngectomy: Regaining Voice and Leading a Normal Life

Laryngectomy survivors can lead fulfilling lives. Thanks to modern rehabilitation techniques and a positive outlook. This was the message from experts and survivors at Rajiv Gandhi Cancer Institute and Research Centre’s (RGCIRC) recent patient programme held at Rohini in the national capital.

|
Zydus,

Zydus, Daewoong Pharmaceutical collaborate for development and commercialisation of Leuprolide Acetate for Depot Suspension

Zydus Worldwide DMCC, a subsidiary of Zydus Lifesciences Ltd and Daewoong Pharmaceutical on Monday announced that they have entered into an exclusive licensing agreement to co-develop and commercialize Leuprolide Acetate for Depot Suspension (RLD: Lupron Depot®, AbbVie) in six dosage strengths for the United States market.

|
Wockhardt

Wockhardt completes Phase 3 pneumonia study of its macrolide antibiotic Nafithromycin WCK 4873

Wockhardt has announced the completion of the pivotal Phase 3 pneumonia Study of its macrolide antibiotic Nafithromycin WCK 4873.

|
Dr. Reddy's Laboratories SA, Dr. Reddy’s, Coya Therapeutics, COYA 302, Amyotrophic Lateral Sclerosis, ALS, Coya Therapeutics Inc,

Dr. Reddy’s collaborates with Coya Therapeutics to treat Amyotrophic Lateral Sclerosis

Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy’s Laboratories Ltd. and Coya Therapeutics have entered into a development

|
Indergiri Finance

Indergiri Finance unveils array of products in financial solutions for healthcare sector

Indergiri Finance Limited has unveiled an array of products for the healthcare sector aimed at Medical Equipment Financing, Patient Financing, and Hospital Receivables Financing.

|